[HTML][HTML] Role of HSP90 in Cancer

B Birbo, EE Madu, CO Madu, A Jain, Y Lu - International journal of …, 2021 - mdpi.com
HSP90 is a vital chaperone protein conserved across all organisms. As a chaperone protein,
it correctly folds client proteins. Structurally, this protein is a dimer with monomer subunits …

Macrocycles in new drug discovery

J Mallinson, I Collins - Future medicinal chemistry, 2012 - Taylor & Francis
The use of drug-like macrocycles is emerging as an exciting area of medicinal chemistry,
with several recent examples highlighting the favorable changes in biological and …

Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock

Z Bikadi, E Hazai - Journal of cheminformatics, 2009 - Springer
Background Molecular docking methods are commonly used for predicting binding modes
and energies of ligands to proteins. For accurate complex geometry and binding energy …

HSP90 inhibitors: current development and potential in cancer therapy

K Sidera, E Patsavoudi - Recent patents on anti-cancer drug …, 2014 - ingentaconnect.com
In the last decade, the molecular chaperone HSP90 has emerged as an important target in
cancer therapeutics and has subsequently become the focus of several drug discovery and …

Hsp90: structure and function

SE Jackson - Molecular chaperones, 2013 - Springer
Hsp90 is a highly abundant and ubiquitous molecular chaperone which plays an essential
role in many cellular processes including cell cycle control, cell survival, hormone and other …

The Hsp90 molecular chaperone: an open and shut case for treatment

LH Pearl, C Prodromou, P Workman - Biochemical Journal, 2008 - portlandpress.com
The molecular chaperone Hsp90 (90 kDa heat-shock protein) is a remarkably versatile
protein involved in the stress response and in normal homoeostatic control mechanisms. It …

New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential

Y Li, T Zhang, SJ Schwartz, D Sun - Drug Resistance Updates, 2009 - Elsevier
The molecular chaperone Hsp90 (heat shock protein 90) is a promising target in cancer
therapy. Preclinical and clinical evaluations of a variety of Hsp90 inhibitors have shown anti …

Natural product inspired N‐terminal Hsp90 inhibitors: from bench to bedside?

A Khandelwal, VM Crowley… - Medicinal research …, 2016 - Wiley Online Library
The 90 kDa heat shock proteins (Hsp90) are responsible for the conformational maturation
of nascent polypeptides and the rematuration of denatured proteins. Proteins dependent …

Small molecule modulators of protein–protein interactions: selected case studies

M Aeluri, S Chamakuri, B Dasari, SKR Guduru… - Chemical …, 2014 - ACS Publications
There is growing interest within the pharmaceutical community to undertake biological
targets that involve protein− protein 1 and, in general, biomacromolecular interactions 2 (PPI …

Natural HSP90 inhibitors as a potential therapeutic intervention in treating cancers: A comprehensive review

HY Liew, XY Tan, HH Chan, KY Khaw… - Pharmacological Research, 2022 - Elsevier
Abstract Heat shock protein 90 (Hsp90) has evolved as a cancerous cell growth regulator by
stabilising various oncogenic kinases. Upon the Hsp90 inhibition, the expression of its client …